-
Most Popular
Healthcare Stocks
Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.
7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024
These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.
7 Dependable Dividend Stocks for Long-Term Income
Explore the best dividend stocks for long-term income excelling in the healthcare, retail, tobacco and home improvement markets.
3 Pharmaceutical Stocks That Can Surge Higher Even if The Markets Correct
These are the pharmaceutical stocks to buy as they represent undervalued companies with a deep clinical pipeline that will support growth.
Other industries you might be interested in
Recent Healthcare Stocks Articles
Have Patience With Aurora Cannabis Stock
ACB stock is a long-term winner that won't get on its long-term winning path until near-term operational risks pass.
Why the Slide of Tilray Stock May Continue
Tilray stock has been stuck in a multi-quarter decline, and the fundamentals imply that the slide of TLRY stock may not be over.
Hexo Stock Might Rebound in 2020
Although HEXO is facing multiple challenges now, including higher costs, the longer term outlook of Hexo stock is upbeat.
Cronos Stock Will Eventually Rebound, but Not Anytime Soon
Like many other high quality pot stocks, CRON stock will eventually rebound from this sell-off, but not here, and not now.
It’s All About the Weed for Aphria Stock
While Aphria’s growth capacity expansion is big news, a more critical catalyst for Aphria stock could be its medicinal marijuana brand.
Why Canopy Growth Stock Can Rise in the Long-Term
CGC's focus on clinical trials and evidence-based medicinal use is likely to be positive for CGC stock over the long-term.
Is November the Time to Buy Aurora Cannabis Stock?
Unless ACB stock's sales growth translates into profits, there is likely to be little upside potential in the share price.
Holiday Spirits Are High Thanks to Canopy Growth’s Edibles
Cannabis-infused beverages and edibles are now legal in Canada. Canopy Growth has a responsible plan. That’s good for CGC stock.
The Overblown Squarepocalypse Melodrama Won’t Stop Square Stock
Square stock may have incurred some negative press from raising its merchant transaction costs, but the overall picture for the company remains bright.
Hexo Stock Is Far Too Dangerous at This Point
Hexo stock price is cheaper, but hardly cheap enough for a business that appears to be in disarray.
We’ve Reached the Must-Hold Support Point for Aurora Cannabis Stock
Aurora Cannabis has been decimated. It has a potentially tradable bottom, but there's not much to love about ACB stock now.
Aurora Cannabis Stock Needs Some Christmas Magic
So far, pot smokers don't want to give their money to the legal side of the business. For investors, that means ACB stock is a name to avoid.
Canopy Growth Stock Can Climb, But How Much Is Debatable
Canopy Growth stock has been caught up in the slump affecting all marijuana stocks, but CGC appears sturdier than its rivals.
Two Key Reasons Not to Buy the Dip in Canopy Growth Stock
Near the lows, CGC stock might look tempting. But investors should keep two troublesome factors in mind when it comes to Canopy Growth stock.
Don’t Count on Altria to Keep the Price of Cronos Stock Propped Up
Cronos stock is severely overvalued and is likely to fall further. Cronos is more expensive than any other Canadian cannabis stock, even despite the recent Altria investment
Aurora Cannabis Stock Still Offers Long-Term Growth Opportunity
The downgrades and the pullback in ACB stock have led to overkill. The stock is now obscenely oversold at double-bottom support.
Has Aurora Cannabis Stock Finally Bottomed Out?
With the Canadian recreational cannabis market finally gaining some steam, is ACB stock poised to recover from its seven-month slump?
4 Key Players Just Held a Marijuana Summit
The governors of four important U.S. states just got together to discuss marijuana legalization. Now's the time to get in cannabis stocks!
Friday’s Vital Data: Intel, Tesla and Cronos Group
Options trading was hot in Intel, Tesla and Cronos Group stocks on Thursday. Here’s what the data suggests moving forward.
